Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes
出版年份 2019 全文链接
标题
Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes
作者
关键词
CYP, Paclitaxel, Docetaxel, Ritonavir, Intratumoral
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 84, Issue 3, Pages 487-499
出版商
Springer Science and Business Media LLC
发表日期
2019-07-15
DOI
10.1007/s00280-019-03905-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
- (2019) Adriana C. Rodriguez et al. Hormones & Cancer
- A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir
- (2019) Vincent A. de Weger et al. CLINICAL CANCER RESEARCH
- A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir
- (2017) Vincent A. de Weger et al. EUROPEAN JOURNAL OF CANCER
- The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma
- (2017) Mao Qixing et al. TUMOR BIOLOGY
- Resensitization of Akt Induced Docetaxel Resistance in Breast Cancer by ‘Iturin A’ a Lipopeptide Molecule from Marine Bacteria Bacillus megaterium
- (2017) Goutam Dey et al. Scientific Reports
- A phase I dose-escalation trial of bi-daily (BID) weekly oral docetaxel as ModraDoc006 in combination with ritonavir
- (2016) V.A. de Weger et al. ANNALS OF ONCOLOGY
- Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications
- (2016) Catia Marzolini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway
- (2016) Xiaohui Zhang et al. PLoS One
- Development of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast Cancer
- (2015) Huixin Yu et al. AAPS Journal
- Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model
- (2015) Jeroen J.M.A. Hendrikx et al. INTERNATIONAL JOURNAL OF CANCER
- CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation
- (2015) Hamid Zia et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- CYP3A4 Expression in Breast Cancer and its Association with Risk Factors in Mexican Women
- (2014) Esau Floriano-Sanchez et al. Asian Pacific Journal of Cancer Prevention
- Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation
- (2014) J J M A Hendrikx et al. BRITISH JOURNAL OF CANCER
- Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure
- (2014) Michelle A. Rudek et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach
- (2014) Sonam Tulsyan et al. GENE
- Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines
- (2013) Wen-Jing Li et al. MOLECULAR BIOLOGY REPORTS
- Modulation of Xenobiotic Receptors by Steroids
- (2013) Monimoy Banerjee et al. MOLECULES
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
- (2012) N. Mitsiades et al. CANCER RESEARCH
- Contributions of Human Enzymes in Carcinogen Metabolism
- (2012) Slobodan Rendic et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
- (2012) Jordi Codony-Servat et al. PROSTATE
- Ritonavir-boosted protease inhibitors in HIV therapy
- (2011) Mark W. Hull et al. ANNALS OF MEDICINE
- Ten Years of Docetaxel-Based Therapies in Prostate Adenocarcinoma: A Systematic Review and Meta-Analysis of 2244 Patients in 12 Randomized Clinical Trials
- (2011) Ary Serpa Neto et al. Clinical Genitourinary Cancer
- Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling
- (2011) Lu Gan et al. PROSTATE
- CYP3A4 expression to predict treatment response to docetaxel for metastasis and recurrence of primary breast cancer
- (2011) Kenichi Sakurai et al. SURGERY TODAY
- Profiling the expression of cytochrome P450 in breast cancer
- (2010) Graeme I Murray et al. HISTOPATHOLOGY
- The structure and allosteric regulation of glutamate dehydrogenase
- (2010) Ming Li et al. NEUROCHEMISTRY INTERNATIONAL
- Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir
- (2010) I. F. Sevrioukova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
- (2009) S. Germano et al. CURRENT CANCER DRUG TARGETS
- Cytochrome P450-mediated metabolism in the human gut wall
- (2009) Jennifer B. Dressman et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells
- (2009) Sanjeev Kumar et al. Molecular Cancer
- Expression of Cytochrome P450 3A4 and Its Clinical Significance in Human Prostate Cancer
- (2009) Tetsuya Fujimura et al. UROLOGY
- Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor
- (2008) S. Harmsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Expression and activity of taxane-metobolizing enzymes in ovarian tumors
- (2007) Julie A. DeLoia et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More